The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design

Biochem Biophys Res Commun. 2021 Jan 29:538:104-107. doi: 10.1016/j.bbrc.2020.10.109. Epub 2020 Nov 5.

Abstract

The development of the SARS-CoV-2 pandemic has prompted an extensive worldwide sequencing effort to characterise the geographical spread and molecular evolution of the virus. A point mutation in the spike protein, D614G, emerged as the virus spread from Asia into Europe and the USA, and has rapidly become the dominant form worldwide. Here we review how the D614G variant was identified and discuss recent evidence about the effect of the mutation on the characteristics of the virus, clinical outcome of infection and host immune response.

Keywords: Coronavirus; Mutation; Neutralising antibody; SARS-CoV-2; Spike.

Publication types

  • Review

MeSH terms

  • Amino Acid Substitution
  • Aspartic Acid / genetics
  • COVID-19 / prevention & control
  • COVID-19 / virology*
  • COVID-19 Vaccines / genetics
  • COVID-19 Vaccines / immunology*
  • Evolution, Molecular*
  • Glycine / genetics
  • Humans
  • Immunogenicity, Vaccine
  • SARS-CoV-2 / genetics*
  • SARS-CoV-2 / pathogenicity*
  • Severity of Illness Index
  • Spike Glycoprotein, Coronavirus / genetics*
  • Spike Glycoprotein, Coronavirus / immunology

Substances

  • COVID-19 Vaccines
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • Aspartic Acid
  • Glycine